Information & safety notice

Vendors, suppliers, products, services, prices, and Group Buys mentioned on PepBuster are shown for general informational and educational purposes only.

PepBuster does not endorse, verify, recommend, or guarantee the legality, safety, quality, availability, legitimacy, or accuracy of any third party, product, service, or information listed here.

Nothing on this site is medical, legal, financial, or safety advice, nor encouragement to buy, use, possess, distribute, or engage in any illegal, regulated, or potentially harmful activity. Do your own research, comply with applicable law, and seek qualified professional advice where appropriate.

To the fullest extent permitted by applicable law, PepBuster is not responsible for losses, damage, injury, or other consequences arising from reliance on or use of this information.

About PepBuster

A public reference tool for comparing offers, tracking price changes, and asking better questions before joining a Group Buy.

What PepBuster is

Purpose

PepBuster is not a blacklist and is not built to put anyone at fault. Its purpose is to help the community identify good offers, understand price movements, compare real costs, and separate reliable Group Buys from questionable ones.

The site keeps price observations, including expired catalogs and campaigns, so that claims can be checked against historical data instead of memory or screenshots alone.

How to use it

Use Products and Lowest Prices to compare offers. Use History to check how a price changed over time. Use Group Buy to review deadlines, MOQ claims, testing, guarantees, and organizer fees.

Prices are imported from seller catalogs and campaign data. PepBuster has no live stock information, does not sell products, and cannot replace direct confirmation with a seller or organizer.

How PepBuster works

Data and limitations

Every catalog, warehouse update, Group Buy, and promotion creates price observations. Observations are kept as dated source data; records, averages, and historical lows are calculated from them and can be recalculated later.

USD is the reference currency. Prices imported in another supported currency are converted to USD using the stored exchange rate when derived data is regenerated; the original source document remains the reference. A listed test belongs only to the named vendor, product, dosage, and batch context; confirm current stock and testing before ordering.

Each history row identifies its source and document reference. A catalog disappearing from current offers does not erase its historical observation.

Catalog requirements: Submissions must contain structured product data, clear batch or dosage references, and explicit pricing. Standardized, machine-readable formats are prioritized for integration.

Corrections and right of reply

PepBuster can be wrong. Vendors, organizers, and community members are encouraged to report incorrect data or provide additional evidence. Verifiable corrections are applied regardless of who submits them. Historical records are corrected transparently rather than silently rewritten where appropriate.

Requests to remove data are refused by default unless there is a valid, evidenced reason. PepBuster does not publish GBO or vendor contact details, except where a seller has included them in its own price list. Access to Group Buys must be moderated by GBOs and their teams; this site is not responsible for the actions or waves of users that may follow publication. It is also not a source of private or additional information about a Group Buy or vendor.

Principles

Approach

This project is not about personal conflicts. The concern is specific behavior: unclear pricing, unverifiable MOQ claims, hidden fees, misleading comparisons, or avoiding reasonable questions.

People can disagree. The real problem starts when criticism is treated as a personal attack instead of a chance to verify facts and improve transparency.

Any single action may have a valid explanation. Transparency is the key. When information is hidden and several warning signs build up, users should look for the wider pattern: limiting competition, controlling access to buyers, or concentrating money and decisions in the same hands.

Health claims and sterile handling

Medical credentials, claimed or genuine, do not make an unverified product, a marketplace peptide, or an unsupported benefit claim trustworthy. A clinical-looking label, a confident explanation, or a professional title is not evidence of identity, purity, sterility, efficacy, or safety.

Be especially cautious when someone sells or promotes products known to have uncertain provenance, promises effects that have no credible basis, or prepares injectable material in an uncontrolled home environment. Reconstituting with fluid from a non-sterile container, using unvalidated handling practices, or allowing contamination risks around preparation is not acceptable research or medical practice.

Ask for verifiable product identity, batch-specific testing where relevant, sterile handling evidence, and a clear separation between evidence, speculation, and sales claims. If those cannot be provided, do not let status or confidence replace basic scrutiny.

Selective harm reduction and the DIY double standard

Community leaders and moderators frequently shut down discussions around DIY, homebrew formulations, or self-prepared solutions under the banner of ā€œuser safety.ā€

  • The baseline reality: The entire space revolves around unapproved, grey-market compounds without pharmaceutical licensing. Pretending that a pre-packaged reseller vial is inherently medical-grade while compound-level knowledge is an unacceptable risk is a self-serving double standard.
  • Harm reduction requires education, not censorship: Understanding sterile techniques, accurate unit conversions, filtration, and storage can help people identify and reduce risks, but it cannot establish sterility, identity, or suitability. Gatekeeping technical knowledge keeps users dependent and uninformed.
  • Knowledge vs. Gatekeeping: Banning discussion on open methods, bulk sourcing, or homebrewing can serve to protect seller markups on pre-made kits rather than user well-being. Open-source problem solving and cost transparency are essential to harm reduction.

Why there are no use protocols

PepBuster deliberately does not publish product ā€œprotocolsā€ or dosage schedules. In many communities, these are personal dosing ideas repeated until they look like an official method; repetition is not validation. PepBuster may document what vendors or communities claim, but documenting a claim does not turn it into a recommendation.

Some authorised medicines, including certain GLP-based treatments, have official prescribing information. Even then, it may change as evidence evolves and it cannot replace individual clinical assessment, response, results, contraindications, or safety monitoring.

The problem is obvious with 5-Amino-1MQ: community and website suggestions can differ by a factor of ten, from a few milligrams to 50 mg per day, while 10 Ɨ 500 mg kits now exist. That range is not evidence for any of those amounts; it is exactly why this site will not select one community claim and present it as the answer.

Commercial conflicts

Community groups should clearly disclose relationships with sellers, reshippers, and companies whose products they promote. Members should be able to question those relationships without being punished or ignored.

Hardware and closed ecosystems: Scrutiny extends to operational tooling (such as proprietary thermal printers with artificial consumable locks or mandatory chips). Users are encouraged to evaluate total cost of ownership and open alternatives rather than relying on locked ecosystems promoted as exclusive standards.

Companies should not use community feedback to create ā€œpremiumā€ products with a medical-looking design that can make resale listings look pharmaceutical. A label design is not proof of quality, testing, legitimacy, or medical status.

ā€œGold Standardā€ monopolies and accessory markups

Conflicts of interest frequently extend to accessories, consumables, and reconstitution supplies:

  • The ā€œGold Standardā€ excuse: Admins and group buy organizers may push specific high-margin brands that they, their teams, or close associates resell (e.g. Hospira bacteriostatic water at extreme markups, or proprietary injection pens priced at 3x–4x their baseline value) while dismissing functional generic alternatives (such as standard Chinese pens or documented sterile diluents) as ā€œshit options.ā€
  • Manufactured fear for margin protection: Misrepresenting the risks of less expensive alternatives, or using fear to make a reseller’s own high-margin inventory appear mandatory, may be used to protect margins rather than support informed choice.
  • Separating facts from sales pitches: Honest guidance acknowledges the distinction: pharmaceutical products such as Hospira bacteriostatic water may provide stronger traceability and manufacturing controls than DIY alternatives. DIY can be less expensive and may remain a viable option, but it carries additional risks that should be stated plainly. Presenting a reseller’s product as the only acceptable option while concealing a financial interest or overstating alternative risks is misleading.

Who runs it

Creator & funding

PepBuster is run independently by 6. It is not affiliated with any vendor, reshipper, Group Buy, or community group, and 6 does not own or operate a group connected to this project. The goal is straightforward: build a public utility driven by transparency, not monetization.

The creator sells no products. No vendor or organizer can pay to be listed or ranked more favourably. Affiliate links may occasionally be shared, but they will always be explicitly identified.

✈ Contact 6 on Telegram

Donations are welcome solely to cover project costs. Once current maintenance costs are covered, additional donations will be declined or reserved transparently for future site expenses, such as improvements and integrating new price sources. Donations never influence catalog inclusion, data, comparisons, or rankings.